| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |